Robert C. Elston
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Robert C. Elston has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Dawn M. Waterworth
J&J Innovative Medicine, Spring House, PA, United States
2 shared publications - Qing Lu
Department of Epidemiology and Biostatistics, Case Western Reserve University, Case Western Reserve University, 2103 Cornell Road, Wolstein Research Building, Room 1304, Cleveland, Ohio 44106, USA
2 shared publications Sungho Won
Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
2 shared publicationsAnne Gabriel
Ministry of Health, Victoria, Seychelles
1 shared publication- Chin Bin Eap
Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Prilly, Switzerland
1 shared publication Georgia Wiesner
Ireland Comprehensive Cancer Center at University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 3 Department of Genetics, Case Western Reserve University, Cleveland, OH
1 shared publication
Latest Publications
- 4 February 2009
- Published by Wiley in Genetic Epidemiology
- Vol. 33 (6) , 463-478
Phase uncertainty in case‐control association studies
The possible evidence for association comprises three types of information: differences between cases and controls in allele frequencies, in parameters for Hardy‐Weinberg disequilibrium (HWD), and in parameters for linkage disequilibrium (LD). LD between marker and disease alleles results in a difference in at least one of the three types of parameters [Won and Elston, 2008]. However, the parameters for LD require knowledge about phase, which is usually unknown, making the LD contrast test without modification infeasible in practice. Methods for handling phase uncertainty are: (1) the most probable haplotype pair for each individual can be considered as the true phase; (2) a weighted average of haplotypes can be used; (3) we can consider the composite LD, which does not require any information about phase. We compare these methods to handle phase uncertainty in terms of validity and efficiency, and the effect on them of HWD in the population, at the same time confirming results for the three types of information. When the LD between markers is high, the LD contrast test that uses a weighted average of haplotypes or the most probable haplotypes to calculate the LD is recommended, but otherwise the LD contrast test that uses the composite LD is recommended. We conclude that, even though the difference in allele frequencies is usually the most informative test except in the case of a recessive disease, the LD contrast test can be more powerful if the markers are dense enough. Genet. Epidemiol. 33:463–478, 2009.
- 4 February 2009
- Published by Wiley in Genetic Epidemiology
- Vol. 33 (6) , 463-478
Phase uncertainty in case‐control association studies
The possible evidence for association comprises three types of information: differences between cases and controls in allele frequencies, in parameters for Hardy‐Weinberg disequilibrium (HWD), and in parameters for linkage disequilibrium (LD). LD between marker and disease alleles results in a difference in at least one of the three types of parameters [Won and Elston, 2008]. However, the parameters for LD require knowledge about phase, which is usually unknown, making the LD contrast test without modification infeasible in practice. Methods for handling phase uncertainty are: (1) the most probable haplotype pair for each individual can be considered as the true phase; (2) a weighted average of haplotypes can be used; (3) we can consider the composite LD, which does not require any information about phase. We compare these methods to handle phase uncertainty in terms of validity and efficiency, and the effect on them of HWD in the population, at the same time confirming results for the three types of information. When the LD between markers is high, the LD contrast test that uses a weighted average of haplotypes or the most probable haplotypes to calculate the LD is recommended, but otherwise the LD contrast test that uses the composite LD is recommended. We conclude that, even though the difference in allele frequencies is usually the most informative test except in the case of a recessive disease, the LD contrast test can be more powerful if the markers are dense enough. Genet. Epidemiol. 33:463–478, 2009.
- Open Access
- 2 June 2008
- Published by Springer Nature in BMC Medical Genomics
- Vol. 1 (1) , 21
Association of ABCB1genetic variants with renal function in Africans and in Caucasians
Background: The P-glycoprotein, encoded by theABCB1gene, is expressed in human endothelial and mesangial cells, which contribute to control renal plasma flow and glomerular filtration rate. We investigated the association ofABCB1variants with renal function in African and Caucasian subjects.Methods: In Africans (290 subjects from 62 pedigrees), we genotyped the2677G>Tand3435 C>T ABCB1polymorphisms. Glomerular filtration rate (GFR) was measured using inulin clearance and effective renal plasma flow (ERPF) using para-aminohippurate clearance. In Caucasians (5382 unrelated subjects), we analyzed 30 SNPs located within and aroundABCB1, using data from the Affymetrix 500 K chip. GFR was estimated using the simplified Modification of the Diet in Renal Disease (MDRD) and Cockcroft-Gault equations.Results: In Africans, compared to the reference genotype (GG or CC), each copy of the2677Tand3435Tallele was associated, respectively, with: GFR higher by 10.6 ± 2.9 (P< 0.001) and 4.4 ± 2.3 (P= 0.06) mL/min; ERPF higher by 47.5 ± 11.6 (P< 0.001) and 28.1 ± 10.5 (P= 0.007) mL/min; and renal resistances lower by 0.016 ± 0.004 (P< 0.001) and 0.011 ± 0.004 (P= 0.004) mm Hg/mL/min. In Caucasians, we identified 3 polymorphisms in theABCB1gene that were strongly associated with all estimates of GFR (smallest P value = 0.0006, overall P = 0.014 after multiple testing correction).Conclusion: Variants of theABCB1gene were associated with renal function in both Africans and Caucasians and may therefore confer susceptibility to nephropathy in humans. If confirmed in other studies, these results point toward a new candidate gene for nephropathy in humans.
- 2 June 2008
- Published by Springer Nature in BMC Medical Genomics
- Vol. 1 (1) , 21
Open AccessAssociation of ABCB1genetic variants with renal function in Africans and in Caucasians
Background: The P-glycoprotein, encoded by theABCB1gene, is expressed in human endothelial and mesangial cells, which contribute to control renal plasma flow and glomerular filtration rate. We investigated the association ofABCB1variants with renal function in African and Caucasian subjects.Methods: In Africans (290 subjects from 62 pedigrees), we genotyped the2677G>Tand3435 C>T ABCB1polymorphisms. Glomerular filtration rate (GFR) was measured using inulin clearance and effective renal plasma flow (ERPF) using para-aminohippurate clearance. In Caucasians (5382 unrelated subjects), we analyzed 30 SNPs located within and aroundABCB1, using data from the Affymetrix 500 K chip. GFR was estimated using the simplified Modification of the Diet in Renal Disease (MDRD) and Cockcroft-Gault equations.Results: In Africans, compared to the reference genotype (GG or CC), each copy of the2677Tand3435Tallele was associated, respectively, with: GFR higher by 10.6 ± 2.9 (P< 0.001) and 4.4 ± 2.3 (P= 0.06) mL/min; ERPF higher by 47.5 ± 11.6 (P< 0.001) and 28.1 ± 10.5 (P= 0.007) mL/min; and renal resistances lower by 0.016 ± 0.004 (P< 0.001) and 0.011 ± 0.004 (P= 0.004) mm Hg/mL/min. In Caucasians, we identified 3 polymorphisms in theABCB1gene that were strongly associated with all estimates of GFR (smallest P value = 0.0006, overall P = 0.014 after multiple testing correction).Conclusion: Variants of theABCB1gene were associated with renal function in both Africans and Caucasians and may therefore confer susceptibility to nephropathy in humans. If confirmed in other studies, these results point toward a new candidate gene for nephropathy in humans.
- 15 May 2008
- Published by Wiley in Genetic Epidemiology
- Vol. 32 (8) , 731-756
The power of independent types of genetic information to detect association in a case‐control study design
There have been many single nucleotide polymorphism‐based tests suggested for association analysis in a case‐control design. The possible evidence for association comprises three types of information: differences between cases and controls in allele frequencies, in parameters for Hardy Weinberg disequilibrium (HWD) and in parameters for linkage disequilibrium (LD). Here, first we find the pairwise covariances between statistics that measure these three types of information and show that the statistics are asymptotically trivariate normally distributed. Then we compare their power analytically to determine the most informative statistics according to the disease model. Our results show that differences in parameters for HWD are informative for dominant and recessive disease models, while differences in allele frequencies and in parameters for LD are generally informative except for rare recessive disease models. There is mutual independence of the statistics that detect these three differences under Hardy Weinberg equilibrium at the marker locus and linkage equilibrium between markers in the population. Knowing the pairwise covariances between the statistics makes it possible to define statistics that are mutually independent. This allows us to perform sequential analyses of the same data without the need to adjust significance levels for all the multiple analyses being performed on the same data set. As a result we can have improved flexible strategies to increase the power of genome‐wide association studies without requiring the collection of a new, independent sample. Genet. Epidemiol. 2008.
- 15 May 2008
- Published by Wiley in Genetic Epidemiology
- Vol. 32 (8) , 731-756
The power of independent types of genetic information to detect association in a case‐control study design
There have been many single nucleotide polymorphism‐based tests suggested for association analysis in a case‐control design. The possible evidence for association comprises three types of information: differences between cases and controls in allele frequencies, in parameters for Hardy Weinberg disequilibrium (HWD) and in parameters for linkage disequilibrium (LD). Here, first we find the pairwise covariances between statistics that measure these three types of information and show that the statistics are asymptotically trivariate normally distributed. Then we compare their power analytically to determine the most informative statistics according to the disease model. Our results show that differences in parameters for HWD are informative for dominant and recessive disease models, while differences in allele frequencies and in parameters for LD are generally informative except for rare recessive disease models. There is mutual independence of the statistics that detect these three differences under Hardy Weinberg equilibrium at the marker locus and linkage equilibrium between markers in the population. Knowing the pairwise covariances between the statistics makes it possible to define statistics that are mutually independent. This allows us to perform sequential analyses of the same data without the need to adjust significance levels for all the multiple analyses being performed on the same data set. As a result we can have improved flexible strategies to increase the power of genome‐wide association studies without requiring the collection of a new, independent sample. Genet. Epidemiol. 2008.
- Open Access
- 18 December 2007
- Published by Springer Nature in BMC Proceedings
- Vol. 1 (S1) , S139
Two-stage analysis strategy for identifying the IgM quantitative trait locus
Genetic association studies offer an opportunity to find genetic variants underlying complex human diseases. Various tests have been developed to improve their power. However, none of these tests is uniformly best and it is usually unclear at the outset what test is best for a specific dataset. For example, Hotelling's T2 test is best for normally distributed data, but it can lose considerable power when normality is not met. To achieve satisfactory power in most cases, without compromising the overall significance level, we propose to adopt a two-stage adaptive analysis strategy – several statistics are compared on a portion of the samples at the first stage and the most powerful statistic is then used for the remaining samples. We evaluated this procedure by mapping the quantitative trait locus of IgM with the simulated data in Genetic Analysis Workshop 15 Problem 3. The results show that the gain in power of the two-stage adaptive analysis procedure could be considerable when the initial choice of test statistic is wrong, whereas the loss is relatively small in the case that the optimal test chosen initially is correct.
- 18 December 2007
- Published by Springer Nature in BMC Proceedings
- Vol. 1 (S1) , S139
Open AccessTwo-stage analysis strategy for identifying the IgM quantitative trait locus
Genetic association studies offer an opportunity to find genetic variants underlying complex human diseases. Various tests have been developed to improve their power. However, none of these tests is uniformly best and it is usually unclear at the outset what test is best for a specific dataset. For example, Hotelling's T2 test is best for normally distributed data, but it can lose considerable power when normality is not met. To achieve satisfactory power in most cases, without compromising the overall significance level, we propose to adopt a two-stage adaptive analysis strategy – several statistics are compared on a portion of the samples at the first stage and the most powerful statistic is then used for the remaining samples. We evaluated this procedure by mapping the quantitative trait locus of IgM with the simulated data in Genetic Analysis Workshop 15 Problem 3. The results show that the gain in power of the two-stage adaptive analysis procedure could be considerable when the initial choice of test statistic is wrong, whereas the loss is relatively small in the case that the optimal test chosen initially is correct.
- Open Access
- 18 December 2007
- Published by Springer Nature in BMC Proceedings
- Vol. 1 (S1) , S147
Genome-wide association studies using an adaptive two-stage analysis for a case-control design
A new type of test is presented for genome-wide association studies using a case-control design. It is referred to as the adaptive two-stage (ATS) analysis, being based on both the Hardy-Weinberg disequilibrium trend test (HWDTT) and the Cochran-Armitage trend test (CATT). The procedure for the ATS is to screen single-nucleotide polymorphisms (SNPs) using the HWDTT in a first stage, and then test a reduced number of SNPs that pass the screening step in a second stage using the CATT. In the Genetic Analysis Workshop 15 simulated data set, this ATS analysis captured, after Bonferroni correction, the region from 32447.149 kb to 32859.819 kb and the region around 37363.880 kb that are close to the actual trait loci on chromosome 6. We compared the ATS with other ways of combining the p-values of the HWDTT and the CATT, the classical form of Fisher's test and a weighted form of Fisher's test. Results showed that the proposed ATS has good performance and could detect the regions containing a susceptibility locus.
- 18 December 2007
- Published by Springer Nature in BMC Proceedings
- Vol. 1 (S1) , S147
Open AccessGenome-wide association studies using an adaptive two-stage analysis for a case-control design
A new type of test is presented for genome-wide association studies using a case-control design. It is referred to as the adaptive two-stage (ATS) analysis, being based on both the Hardy-Weinberg disequilibrium trend test (HWDTT) and the Cochran-Armitage trend test (CATT). The procedure for the ATS is to screen single-nucleotide polymorphisms (SNPs) using the HWDTT in a first stage, and then test a reduced number of SNPs that pass the screening step in a second stage using the CATT. In the Genetic Analysis Workshop 15 simulated data set, this ATS analysis captured, after Bonferroni correction, the region from 32447.149 kb to 32859.819 kb and the region around 37363.880 kb that are close to the actual trait loci on chromosome 6. We compared the ATS with other ways of combining the p-values of the HWDTT and the CATT, the classical form of Fisher's test and a weighted form of Fisher's test. Results showed that the proposed ATS has good performance and could detect the regions containing a susceptibility locus.
- Open Access
- 29 May 2007
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 166 (3) , 246-254
A Meta-Analysis of the Association of N-Acetyltransferase 2 Gene (NAT2) Variants with Breast Cancer
The N-acetyltransferase 2 gene (NAT2) product is an enzyme important in carcinogen metabolism via activation and detoxification pathways. Therefore, NAT2 variants may represent underlying susceptibility to breast cancer. Because a number of studies of the association of NAT2 with breast cancer have been published, the authors performed a meta-analysis. They extracted all relevant data to examine evidence for a main effect (i.e., the effect in a model that does not include any interactions) of NAT2 phenotype and genotype on breast cancer risk. They summarized the evidence for modification by smoking and meat intake, sources of exposure to aromatic and heterocyclic amines, respectively, which are metabolized by NAT2. The authors identified seven studies that measured NAT2 phenotype and 20 studies that deduced phenotype via genotyping. They found no evidence for heterogeneity (Cochran's Q statistic p = 0.74) and no statistically significant increased risk from NAT2 acetylation (slow/rapid) for breast cancer (summary odds ratio = 1.02, 95% confidence interval: 0.95, 1.08). These results suggest that there is no overall association between the NAT2 slow- or rapid-acetylation phenotype and breast cancer risk. However, some evidence suggests that smoking may modify this association.
- 29 May 2007
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 166 (3) , 246-254
Open AccessA Meta-Analysis of the Association of N-Acetyltransferase 2 Gene (NAT2) Variants with Breast Cancer
The N-acetyltransferase 2 gene (NAT2) product is an enzyme important in carcinogen metabolism via activation and detoxification pathways. Therefore, NAT2 variants may represent underlying susceptibility to breast cancer. Because a number of studies of the association of NAT2 with breast cancer have been published, the authors performed a meta-analysis. They extracted all relevant data to examine evidence for a main effect (i.e., the effect in a model that does not include any interactions) of NAT2 phenotype and genotype on breast cancer risk. They summarized the evidence for modification by smoking and meat intake, sources of exposure to aromatic and heterocyclic amines, respectively, which are metabolized by NAT2. The authors identified seven studies that measured NAT2 phenotype and 20 studies that deduced phenotype via genotyping. They found no evidence for heterogeneity (Cochran's Q statistic p = 0.74) and no statistically significant increased risk from NAT2 acetylation (slow/rapid) for breast cancer (summary odds ratio = 1.02, 95% confidence interval: 0.95, 1.08). These results suggest that there is no overall association between the NAT2 slow- or rapid-acetylation phenotype and breast cancer risk. However, some evidence suggests that smoking may modify this association.
- Open Access
- 30 December 2005
- Published by Springer Nature in BMC Genomic Data
- Vol. 6 (S1) , S67
Fine-mapping using the weighted average method for a case-control study
We present a new method for fine-mapping a disease susceptibility locus using a case-control design. The new method, termed the weighted average (WA) statistic, averages the Cochran-Armitage (CA) trend test statistic and the difference between the Hardy-Weinberg disequilibrium test statistic for cases and controls (the HWD trend). The main characteristics of the WA statistic are that it improves on the weaknesses, and maintains the strengths, of both the CA trend test and the HWD trend test. Data from three different populations in the Genetic Analysis Workshop 14 (GAW14) simulated dataset (Aipotu, Karangar, and Danacaa) were first subjected to model-free linkage analysis to find regions exhibiting linkage. Then, for fine-scale mapping, 140 SNPs within the significant linkage regions were analyzed with the WA test statistic on replicates of the three populations, both separately and combined. The regions that were significant in the multipoint linkage analysis were also significant in this fine-scale mapping. The most significant regions that were obtained using the WA statistic were regions in chromosome 3 (B03T3056–B03T3058, p-value < 1 × 10-10 ) and chromosome 9 (B09T8332–B09T8334, p-value 1 × 10-6 ). Based on the results of the simulated GAW14 data, the WA test statistic showed good performance and could narrow down the region containing the susceptibility locus. However, the strength of the signal depends on both the strength of the linkage disequilibrium and the heterozygosity of the linked marker.
- 30 December 2005
- Published by Springer Nature in BMC Genomic Data
- Vol. 6 (S1) , S67
Open AccessFine-mapping using the weighted average method for a case-control study
We present a new method for fine-mapping a disease susceptibility locus using a case-control design. The new method, termed the weighted average (WA) statistic, averages the Cochran-Armitage (CA) trend test statistic and the difference between the Hardy-Weinberg disequilibrium test statistic for cases and controls (the HWD trend). The main characteristics of the WA statistic are that it improves on the weaknesses, and maintains the strengths, of both the CA trend test and the HWD trend test. Data from three different populations in the Genetic Analysis Workshop 14 (GAW14) simulated dataset (Aipotu, Karangar, and Danacaa) were first subjected to model-free linkage analysis to find regions exhibiting linkage. Then, for fine-scale mapping, 140 SNPs within the significant linkage regions were analyzed with the WA test statistic on replicates of the three populations, both separately and combined. The regions that were significant in the multipoint linkage analysis were also significant in this fine-scale mapping. The most significant regions that were obtained using the WA statistic were regions in chromosome 3 (B03T3056–B03T3058, p-value < 1 × 10-10 ) and chromosome 9 (B09T8332–B09T8334, p-value 1 × 10-6 ). Based on the results of the simulated GAW14 data, the WA test statistic showed good performance and could narrow down the region containing the susceptibility locus. However, the strength of the signal depends on both the strength of the linkage disequilibrium and the heterozygosity of the linked marker.